Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Dondorp, AM; Fanello, CI; Hendriksen, IC; Gomes, E; Seni, A; Chhaganlal, KD; Bojang, K; Olaosebikan, R; Anunobi, N; Maitland, K; +32 more... Kivaya, E; Agbenyega, T; Nguah, SB; Evans, J; Gesase, S; Kahabuka, C; Mtove, G; Nadjm, B; Deen, J; Mwanga-Amumpaire, J; Nansumba, M; Karema, C; Umulisa, N; Uwimana, A; Mokuolu, OA; Adedoyin, OT; Johnson, WB; Tshefu, AK; Onyamboko, MA; Sakulthaew, T; Ngum, WP; Silamut, K; Stepniewska, K; Woodrow, CJ; Bethell, D; Wills, B; Oneko, M; Peto, TE; von Seidlein, L; Day, NP; White, NJ; AQUAMAT group; (2010) Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet, 376 (9753). pp. 1647-57. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(10)61924-1

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S0140-6736(10)61924-1

Abstract

Share

Download

Filename: mmc1.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar